People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

by Jon Kelvey

Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

by Emma Yasinski

Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

by Ashley P. Taylor

For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.

by Kate Yandell

From the Editor-in-Chief

DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop.

by William G. Nelson, MD, PhD

Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.

by Kate Yandell

Forward Look

Irene Ghobrial on studying cancer precursors.

by Sue Rochman

Forward Look

At-home genetic tests offer limited information on cancer risk.

by Sharon Tregaskis

Proton therapy, an alternative to standard radiation therapy, is safe and effective. But evidence is lacking that it's always a better option than standard radiation, and some insurers balk at the higher price tag.

by Sue Rochman

Forward Look

E-cigarettes are upending decades of smoke-free successes.

by Nancy Averett